Search the Newsreel

AxoGen Inc (AXGN) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of AxoGen Inc (AXGN), outlining major institutional holders and their proportional ownership. It provides data on shareholding types, institutional holdings over several quarters, and recent shareholder activity with changes in holdings. Additionally, it lists several ETFs that include …

AxoGen Inc (AXGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a brief overview of AxoGen Inc (AXGN) focusing on its revenue breakdown. It states that relevant data for business segments and regional revenue (beyond the United States) have not yet been disclosed by the company for FY2023 and FY2022. The reported …

Wall Street Zen Upgrades AxoGen (NASDAQ:AXGN) to Buy

Wall Street Zen has upgraded AxoGen (NASDAQ:AXGN) from a "hold" to a "buy" rating, contributing to a generally positive analyst outlook for the company. Despite missing EPS estimates in its latest quarter, AxoGen's revenue surpassed expectations, and it holds a "Moderate Buy" consensus rating …

AxoGen Inc (AXGN) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for AxoGen Inc (AXGN), indicating a current earnings forecast score of 8.40 and ranking 35th in its industry. Analysts have an average price target of $36.00 with a "Buy" rating. The company's expected revenue for the next quarter …

AXGN|AxoGen Inc|Price:39.490|Chg%:-0.240

This article provides an in-depth analysis of AxoGen Inc (AXGN), highlighting its strong fundamentals, high growth potential, and fair valuation within the Healthcare Equipment & Supplies industry. It details the company's product portfolio for peripheral nerve regeneration and repair, notes high institutional ownership, and …

Axogen Inc. (AXGN) Q1 2026 Earnings: EPS Falls Short of Estimates, Stock Edges Lower - EBITDA Analysis

Earnings Preview: AxoGen to Report Financial Results Pre-market on July 29

AxoGen is scheduled to report its financial results pre-market on July 29. This article serves as an earnings preview, indicating the upcoming release of the company's financial performance. Investors and analysts will be closely watching the report for insights into AxoGen's recent operational and …

Does NZS Capital’s ‘Optionality’ Stake and Coverage Momentum Change The Bull Case For Axogen (AXGN)?

NZS Capital, LLC’s NZS Growth Equity Strategy recently added Axogen, Inc. as an “optionality” position, citing its peripheral nerve repair grafts and progress in regulatory and insurance coverage. This move highlights growing institutional interest in Axogen's potential to establish peripheral nerve repair as a …

AxoGen (AXGN) Projected to Release Quarterly Earnings on Wednesday

AxoGen (AXGN) is projected to release its Q2 2026 earnings on Wednesday, July 29th, with analysts expecting $0.09 EPS and $67.1 million in revenue. The company previously missed EPS estimates but beat revenue expectations in Q1 2026. While Wall Street maintains a "Moderate Buy" …

NZS Capital Added Axogen (AXGN) as an Optionality Position

NZS Capital has added Axogen, Inc. (NASDAQ: AXGN) to its portfolio as an optionality position, citing its potential for growth if nerve repair becomes a standard of care. The investment firm believes Axogen's Avance nerve allograft, coupled with positive insurance coverage momentum, positions the …

WCM Investment Management LLC Acquires 158,914 Shares of AxoGen, Inc. $AXGN

WCM Investment Management LLC significantly increased its stake in AxoGen, Inc. by 39.7% in the first quarter, purchasing over 158,000 shares, bringing its total to 559,530 shares valued at approximately $17.5 million. Despite missing quarterly EPS estimates, AxoGen's revenue exceeded expectations, and analysts maintain …

(AXGN) and the Role of Price-Sensitive Allocations

Axogen Inc. (NASDAQ: AXGN) is showing weak near and mid-term sentiment, but a strong long

Axogen to report Q2 2026 financial results on J...

Axogen, Inc., a leader in surgical solutions for peripheral nerve repair, is set to announce its second-quarter 2026 financial results on July 29, 2026. Following the release, the company will host a conference call and webcast. This event is significant for investors and stakeholders …

Axogen schedules investor webcast after July 29 results

Axogen (Nasdaq: AXGN) announced it will release its second quarter 2026 financial results on Wednesday, July 29, 2026, followed by a conference call and webcast hosted by management at 8:00 a.m. ET. Investors can access the call via phone or webcast on the Axogen …